During the past decade, Zhongnan Hospital of Wuhan University conducted 117 clinical trials. In the 10-year time frame, 117 clinical trials started and 5 clinical trials were completed, i.e. on average, 4.3% percent of trials that started reached the finish line to date. In the past 5 years, 95 clinical trials started and 2 clinical trials were completed. i.e. 2.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zhongnan Hospital of Wuhan University" #1 sponsor was "Zhongnan Hospital" with 30 trials, followed by "Wuhan University" with 14 trials sponsored, "Zhou Fuxiang" with 5 trials sponsored, "Ascentage Pharma Group Inc." with 4 trials sponsored and "BeiGene" with 4 trials sponsored. Other sponsors include 79 different institutions and companies that sponsored additional 76 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zhongnan Hospital of Wuhan University" #1 collaborator was "Wuhan University" with 5 trials as a collaborator, "Hubei Cancer Hospital" with 4 trials as a collaborator, "The Second Affiliated Hospital of Chongqing Medical University" with 4 trials as a collaborator, "Xiangya Hospital of Central South University" with 4 trials as a collaborator and "Beijing Tiantan Hospital" with 3 trials as a collaborator. Other collaborators include 277 different institutions and companies that were collaborators in the rest 196 trials.

According to Clinical.Site data, the most researched conditions in "Zhongnan Hospital of Wuhan University" are "Gastric Cancer" (5 trials), "Multiple Myeloma" (5 trials), "Breast Cancer" (4 trials), "Epithelial Ovarian Cancer" (4 trials) and "Ovarian Cancer" (4 trials). Many other conditions were trialed in "Zhongnan Hospital of Wuhan University" in a lesser frequency.

Most popular intervention types in "Zhongnan Hospital of Wuhan University" are "Drug" (87 trials), "Procedure" (16 trials), "Device" (14 trials), "Other" (14 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "PET/CT" (3 trials), "APG-2575" (2 trials), "Camrelizumab" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Zhongnan Hospital of Wuhan University" are 122 trials for "All" genders, 13 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 85 active trials in "Zhongnan Hospital of Wuhan University". 5 are not yet recruiting, 67 are recruiting, 11 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 30 completed trials in Zhongnan Hospital of Wuhan University, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Zhongnan Hospital of Wuhan University, 16 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 32 trials that are defined as “Not Applicable".

Zhongnan Hospital of Wuhan University has several departments that took part in Clinical trials: "Department and Institute of Infectious Disease" - 6 trials, "School and Hospital of Stomatology, Wuhan University" - 4 trials, "Gastroenterology" - 2 trials